Joanne Jones

7.4k total citations
64 papers, 3.5k citations indexed

About

Joanne Jones is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Joanne Jones has authored 64 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 27 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Joanne Jones's work include Multiple Sclerosis Research Studies (26 papers), Immunotherapy and Immune Responses (14 papers) and T-cell and B-cell Immunology (12 papers). Joanne Jones is often cited by papers focused on Multiple Sclerosis Research Studies (26 papers), Immunotherapy and Immune Responses (14 papers) and T-cell and B-cell Immunology (12 papers). Joanne Jones collaborates with scholars based in United Kingdom, Italy and United States. Joanne Jones's co-authors include Alasdair Coles, D. A. S. Compston, Amanda Cox, Sara Thompson, G Hale, Herman Waldmann, Orla Tuohy, Alastair Compston, Laura Azzopardi and Grant Hill-Cawthorne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Joanne Jones

60 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne Jones United Kingdom 32 1.8k 1.4k 933 804 505 64 3.5k
A Wajgt Poland 10 2.5k 1.4× 872 0.6× 828 0.9× 1.3k 1.6× 371 0.7× 37 3.3k
Paolo A. Muraro United Kingdom 41 3.8k 2.1× 1.9k 1.4× 1.1k 1.1× 1.4k 1.8× 803 1.6× 128 5.9k
Markus Krumbholz Germany 36 2.3k 1.2× 2.9k 2.1× 1.4k 1.5× 688 0.9× 1.5k 3.1× 69 6.3k
Robin Lincoln United States 24 1.7k 0.9× 1.5k 1.1× 287 0.3× 395 0.5× 641 1.3× 33 3.2k
Mark A. Jensen United States 25 825 0.4× 996 0.7× 239 0.3× 518 0.6× 329 0.7× 56 2.3k
Yu-Min Huang Sweden 27 557 0.3× 1.2k 0.9× 347 0.4× 334 0.4× 517 1.0× 80 2.5k
Stephen Reddel Australia 35 1.2k 0.7× 403 0.3× 1.8k 2.0× 193 0.2× 707 1.4× 118 3.7k
Barbara Serafini Italy 33 4.1k 2.2× 3.3k 2.4× 1.3k 1.4× 1.4k 1.8× 956 1.9× 52 7.3k
Francesco Lolli Italy 34 1.2k 0.7× 552 0.4× 959 1.0× 180 0.2× 666 1.3× 152 3.6k
Philippe Cabre Martinique 27 4.0k 2.2× 882 0.6× 3.1k 3.3× 213 0.3× 568 1.1× 59 5.5k

Countries citing papers authored by Joanne Jones

Since Specialization
Citations

This map shows the geographic impact of Joanne Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Jones more than expected).

Fields of papers citing papers by Joanne Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Jones. The network helps show where Joanne Jones may publish in the future.

Co-authorship network of co-authors of Joanne Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Jones. A scholar is included among the top collaborators of Joanne Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Jones. Joanne Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Joanne, et al.. (2025). TNFSF14 (LIGHT) in intestinal inflammation: balancing immune activation and resolution in IBD. Frontiers in Immunology. 16. 1657071–1657071.
2.
Howlett, Sarah, Lorna B. Jarvis, Daniel B. Rainbow, et al.. (2024). FlowAtlas: an interactive tool for high-dimensional immunophenotyping analysis bridging FlowJo with computational tools in Julia. Frontiers in Immunology. 15. 1425488–1425488. 1 indexed citations
3.
Brown, J William L, Ferrán Prados, Daniel R. Altmann, et al.. (2022). Remyelination varies between and within lesions in multiple sclerosis following bexarotene. Annals of Clinical and Translational Neurology. 9(10). 1626–1642. 14 indexed citations
4.
Howlett, Sarah, et al.. (2021). The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease. PubMed. 5(3). NS20200083–NS20200083. 4 indexed citations
5.
Rainbow, Daniel B., Lorna B. Jarvis, Nick Cunniffe, et al.. (2021). The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation In Vitro. Frontiers in Immunology. 12. 712241–712241. 16 indexed citations
6.
Jones, Joanne. (2020). The immunology of multiple sclerosis. ˜The œbiomedical & life sciences collection.. 2020(7). e1005172–e1005172. 1 indexed citations
7.
Ban, Maria, Amie Baker, Alastair Compston, et al.. (2020). Transcript specific regulation of expression influences susceptibility to multiple sclerosis. European Journal of Human Genetics. 28(6). 826–834. 9 indexed citations
8.
Manavaki, Roido, Doreen Lau, Lorna B. Jarvis, et al.. (2020). Detection limit of 89Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRI. EJNMMI Research. 10(1). 82–82. 13 indexed citations
9.
Kahaly, George J., Joanne Jones, Paul W. Sanders, et al.. (2019). Meeting Abstracts from the 67th Annual British Thyroid Association Meeting. Thyroid Research. 12(S1).
10.
Brown, J William L, Ferrán Prados, Arman Eshaghi, et al.. (2019). Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab. Multiple Sclerosis Journal. 26(9). 1093–1101. 9 indexed citations
11.
Grist, James T., Frank Riemer, Mary A. McLean, et al.. (2018). Imaging intralesional heterogeneity of sodium concentration in multiple sclerosis: Initial evidence from 23 Na-MRI. Journal of the Neurological Sciences. 387. 111–114. 10 indexed citations
12.
Davies, Jessica L., Sara Thompson, Stephen Sawcer, et al.. (2016). Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis. PLoS ONE. 11(7). e0158327–e0158327. 10 indexed citations
13.
Tuohy, Orla, et al.. (2013). Immune competence after alemtuzumab treatment of multiple sclerosis. Neurology. 81(10). 872–876. 102 indexed citations
14.
Azzopardi, Laura, Sara Thompson, Katharine Harding, et al.. (2013). Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 85(7). 795–798. 40 indexed citations
15.
Costelloe, Lisa, Joanne Jones, & Alasdair Coles. (2012). Secondary autoimmune diseases following alemtuzumab therapy for multiple sclerosis. Expert Review of Neurotherapeutics. 12(3). 335–341. 79 indexed citations
16.
Hirst, Claire, J. Llewelyn, M. Cossburn, et al.. (2010). Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy. Journal of Neurology. 257(6). 913–919. 55 indexed citations
17.
Jones, Joanne & Alasdair Coles. (2010). New treatment strategies in multiple sclerosis. Experimental Neurology. 225(1). 34–39. 31 indexed citations
18.
Jones, Joanne, JANE ANDERSON, Chia‐Ling Phuah, et al.. (2010). Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity. Brain. 133(8). 2232–2247. 125 indexed citations
19.
Cox, Amanda, Sara Thompson, Joanne Jones, et al.. (2005). Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. European Journal of Immunology. 35(11). 3332–3342. 238 indexed citations
20.
Jones, Joanne. (1987). Improved cardiac cell with symmetrical biphasic defibrillator waveforms. American Journal of Physiology-Legacy Content. 253.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Wajgt Breakdown of academic impact, for papers by Paolo A. Muraro Breakdown of academic impact, for papers by Markus Krumbholz Breakdown of academic impact, for papers by Robin Lincoln Breakdown of academic impact, for papers by Mark A. Jensen Breakdown of academic impact, for papers by Yu-Min Huang Breakdown of academic impact, for papers by Stephen Reddel Breakdown of academic impact, for papers by Barbara Serafini Breakdown of academic impact, for papers by Francesco Lolli Breakdown of academic impact, for papers by Philippe Cabre
Rankless by CCL
2026